Start free

Natera, Inc. (NTRA) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 13, 2026.

Filings shown
83
Open-market buys
0
Open-market sells
358

Counts cover the 83 most recent Form 4 filings Tradune holds for NTRA (filed May 5 – Nov 13, 2026); the score below covers only the trailing 90 days (0 buys, 177 sells). SEC EDGAR Form 4 filings for NTRA last checked Nov 22, 2026, 09:00 UTC; the latest NTRA filing Tradune holds was filed Nov 13, 2026. This is not guaranteed to be the complete record — see NTRA's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 31 filings Tradune holds for NTRA filed Aug 28 – Nov 13, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

178 open-market sales by Rule 10b5-1 checkbox

On filings with the 10b5-1 box checked
178 sales· 297,336 sh
checkbox disclosed
On filings with the box not checked
0 sales· 0 sh
not proof that no plan exists
Not comparable
0 sales· 0 sh
filed before Apr 1, 2023, or no checkbox value in the filing data

Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Jonathan SheenaDirector 0 76 — 37,104 −$13,839,091
Matthew RabinowitzEXECUTIVE CHAIRMAN 0 57 — 204,466 −$72,324,288
Solomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS 0 21 — 26,751 −$9,467,014
Michael Burkes BrophyCHIEF FINANCIAL OFFICER 0 8 — 5,858 −$2,455,309
Steven Leonard ChapmanCEO AND PRESIDENT 0 7 — 12,466 −$5,017,955
John FeskoPRESIDENT, CHIEF BUS. OFFICER 0 5 — 8,498 −$2,916,155
Daniel RabinowitzSEC. AND CHIEF LEGAL OFFICER 0 4 — 2,193 −$908,017

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

0/ 100

Net insider sales
0 distinct buyers0 buy · 177 sell tx

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at NTRA

No open-market insider purchases (Form 4 code P) were reported for NTRA between May 5, 2026 and Nov 13, 2026. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Jonathan Sheena Director · filed Nov 13, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 40 $315.26 8,210 (indirect) −0.5% Nov 11, 2026
Open-market sale 10b5-1 box checked 85 $316.93 8,125 (indirect) −1.0% Nov 11, 2026
Open-market sale 10b5-1 box checked 145 $317.87 7,980 (indirect) −1.8% Nov 11, 2026
Open-market sale 10b5-1 box checked 240 $319.77 7,740 (indirect) −3.0% Nov 11, 2026
Open-market sale 10b5-1 box checked 160 $320.02 7,580 (indirect) −2.1% Nov 11, 2026
Open-market sale 10b5-1 box checked 40 $322.00 7,540 (indirect) −0.5% Nov 11, 2026
Open-market sale 10b5-1 box checked 40 $323.07 7,500 (indirect) −0.5% Nov 11, 2026
Open-market sale 10b5-1 box checked 40 $315.28 8,210 (indirect) −0.5% Nov 11, 2026
Open-market sale 10b5-1 box checked 48 $317.33 8,162 (indirect) −0.6% Nov 11, 2026
Open-market sale 10b5-1 box checked 182 $317.96 7,980 (indirect) −2.2% Nov 11, 2026
Open-market sale 10b5-1 box checked 240 $319.22 7,740 (indirect) −3.0% Nov 11, 2026
Open-market sale 10b5-1 box checked 120 $320.07 7,620 (indirect) −1.6% Nov 11, 2026
Open-market sale 10b5-1 box checked 80 $322.88 7,540 (indirect) −1.0% Nov 11, 2026
Open-market sale 10b5-1 box checked 40 $324.76 7,500 (indirect) −0.5% Nov 11, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Jonathan Sheena Director · filed Nov 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 15 $304.57 217,597 −0.0% Nov 6, 2026
Open-market sale 10b5-1 box checked 51 $305.75 217,546 −0.0% Nov 6, 2026
Open-market sale 10b5-1 box checked 21 $306.46 217,525 −0.0% Nov 6, 2026
Open-market sale 10b5-1 box checked 50 $308.20 217,475 −0.0% Nov 6, 2026
Open-market sale 10b5-1 box checked 64 $309.08 217,411 −0.0% Nov 6, 2026
Open-market sale 10b5-1 box checked 110 $310.17 217,301 −0.1% Nov 6, 2026
Open-market sale 10b5-1 box checked 100 $311.31 217,201 −0.0% Nov 6, 2026
Open-market sale 10b5-1 box checked 106 $312.20 217,095 −0.0% Nov 6, 2026
Open-market sale 10b5-1 box checked 74 $313.32 217,021 −0.0% Nov 6, 2026
Open-market sale 10b5-1 box checked 108 $314.71 216,913 −0.0% Nov 6, 2026
Open-market sale 10b5-1 box checked 169 $315.48 216,744 −0.1% Nov 6, 2026
Open-market sale 10b5-1 box checked 1,838 $316.87 214,906 −0.8% Nov 6, 2026
Open-market sale 10b5-1 box checked 56 $318.17 214,850 −0.0% Nov 6, 2026
Open-market sale 10b5-1 box checked 105 $319.30 214,745 −0.0% Nov 6, 2026
Open-market sale 10b5-1 box checked 51 $321.12 214,563 −0.0% Nov 6, 2026
Open-market sale 10b5-1 box checked 16 $321.85 214,547 −0.0% Nov 6, 2026
Open-market sale 10b5-1 box checked 40 $323.86 214,507 −0.0% Nov 6, 2026
Open-market sale 10b5-1 box checked 45 $325.05 214,462 −0.0% Nov 6, 2026
Open-market sale 10b5-1 box checked 131 $320.07 214,614 −0.1% Nov 6, 2026
Michael Burkes Brophy CHIEF FINANCIAL OFFICER · filed Nov 4, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 470 $391.49 45,779 −1.0% Nov 3, 2026
Open-market sale 10b5-1 box checked 317 $400.29 46,249 −0.7% Nov 2, 2026
Open-market sale 10b5-1 box checked 8 $388.03 46,566 −0.0% Nov 2, 2026
John Fesko PRESIDENT, CHIEF BUS. OFFICER · filed Nov 4, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 7 $388.20 195,571 −0.0% Nov 2, 2026
Open-market sale 10b5-1 box checked 295 $400.29 195,276 −0.2% Nov 2, 2026
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS · filed Nov 4, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 9 $388.20 104,733 −0.0% Nov 2, 2026
Open-market sale 10b5-1 box checked 760 $415.52 101,563 −0.7% Nov 2, 2026
Open-market sale 10b5-1 box checked 240 $416.45 101,323 −0.2% Nov 2, 2026
Open-market sale 10b5-1 box checked 200 $405.26 104,123 −0.2% Nov 2, 2026
Open-market sale 10b5-1 box checked 432 $406.94 103,691 −0.4% Nov 2, 2026
Open-market sale 10b5-1 box checked 408 $408.08 103,283 −0.4% Nov 2, 2026
Open-market sale 10b5-1 box checked 520 $409.46 102,763 −0.5% Nov 2, 2026
Open-market sale 10b5-1 box checked 120 $410.72 102,643 −0.1% Nov 2, 2026
Open-market sale 10b5-1 box checked 120 $411.73 102,523 −0.1% Nov 2, 2026
Open-market sale 10b5-1 box checked 120 $412.88 102,403 −0.1% Nov 2, 2026
Open-market sale 10b5-1 box checked 80 $414.16 102,323 −0.1% Nov 2, 2026
Open-market sale 10b5-1 box checked 410 $400.29 104,323 −0.4% Nov 2, 2026
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER · filed Nov 4, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 7 $388.20 168,214 −0.0% Nov 2, 2026
Open-market sale 10b5-1 box checked 334 $400.29 167,880 −0.2% Nov 2, 2026
Steven Leonard Chapman CEO AND PRESIDENT · filed Nov 4, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 21 $387.90 91,211 −0.0% Nov 2, 2026
Open-market sale 10b5-1 box checked 914 $400.29 90,297 −1.0% Nov 2, 2026
Open-market sale 10b5-1 box checked 2,866 $415.64 87,431 −3.2% Nov 2, 2026
Jonathan Sheena Director · filed Nov 4, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 3 $388.20 217,683 −0.0% Nov 2, 2026
Open-market sale 10b5-1 box checked 109 $400.29 217,574 −0.1% Nov 2, 2026
Matthew Rabinowitz EXECUTIVE CHAIRMAN · filed Nov 4, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 17 $388.20 2,117,659 −0.0% Nov 2, 2026
Open-market sale 10b5-1 box checked 731 $400.29 2,116,928 −0.0% Nov 2, 2026
Michael Burkes Brophy CHIEF FINANCIAL OFFICER · filed Oct 30, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 1,906 $425.55 46,574 −3.9% Oct 30, 2026
Open-market sale 10b5-1 box checked 865 $426.87 48,480 −1.8% Oct 28, 2026
Open-market sale 10b5-1 box checked 313 $425.32 49,345 −0.6% Oct 28, 2026
John Fesko PRESIDENT, CHIEF BUS. OFFICER · filed Oct 29, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 898 $426.34 195,578 −0.5% Oct 28, 2026
Open-market sale 10b5-1 box checked 781 $406.00 196,476 −0.4% Oct 27, 2026
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS · filed Oct 29, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 1,162 $426.34 104,742 −1.1% Oct 28, 2026
Open-market sale 10b5-1 box checked 1,010 $406.00 105,904 −0.9% Oct 27, 2026
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER · filed Oct 29, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 968 $426.34 168,221 −0.6% Oct 28, 2026
Open-market sale 10b5-1 box checked 884 $406.00 169,189 −0.5% Oct 27, 2026
Steven Leonard Chapman CEO AND PRESIDENT · filed Oct 29, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 3,430 $426.34 91,232 −3.6% Oct 28, 2026
Open-market sale 10b5-1 box checked 2,264 $406.00 94,662 −2.3% Oct 27, 2026
Michael Burkes Brophy CHIEF FINANCIAL OFFICER · filed Oct 29, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 1,198 $426.34 49,658 −2.4% Oct 28, 2026
Open-market sale 10b5-1 box checked 781 $406.00 50,856 −1.5% Oct 27, 2026
Jonathan Sheena Director · filed Oct 29, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 187 $426.34 217,686 −0.1% Oct 28, 2026
Open-market sale 10b5-1 box checked 291 $406.00 217,873 −0.1% Oct 27, 2026
Matthew Rabinowitz EXECUTIVE CHAIRMAN · filed Oct 29, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 1,718 $406.00 2,117,676 −0.1% Oct 27, 2026
Jonathan Sheena Director · filed Oct 23, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 200 $406.50 221,114 −0.1% Oct 21, 2026
Open-market sale 10b5-1 box checked 962 $408.26 220,152 −0.4% Oct 21, 2026
Open-market sale 10b5-1 box checked 627 $409.89 219,525 −0.3% Oct 21, 2026
Open-market sale 10b5-1 box checked 605 $411.32 218,920 −0.3% Oct 21, 2026
Open-market sale 10b5-1 box checked 211 $412.20 218,709 −0.1% Oct 21, 2026
Open-market sale 10b5-1 box checked 125 $413.05 218,584 −0.1% Oct 21, 2026
Open-market sale 10b5-1 box checked 255 $415.67 218,329 −0.1% Oct 21, 2026
Open-market sale 10b5-1 box checked 165 $416.67 218,164 −0.1% Oct 21, 2026
Jonathan Sheena Director · filed Oct 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 215 $399.34 8,785 (indirect) −2.4% Oct 16, 2026
Open-market sale 10b5-1 box checked 280 $401.29 8,505 (indirect) −3.2% Oct 16, 2026
Open-market sale 10b5-1 box checked 90 $404.25 8,415 (indirect) −1.1% Oct 16, 2026
Open-market sale 10b5-1 box checked 50 $405.15 8,365 (indirect) −0.6% Oct 16, 2026
Open-market sale 10b5-1 box checked 35 $406.63 8,330 (indirect) −0.4% Oct 16, 2026
Open-market sale 10b5-1 box checked 80 $409.36 8,250 (indirect) −1.0% Oct 16, 2026
Open-market sale 10b5-1 box checked 142 $398.95 8,858 (indirect) −1.6% Oct 16, 2026
Open-market sale 10b5-1 box checked 280 $400.68 8,578 (indirect) −3.2% Oct 16, 2026
Open-market sale 10b5-1 box checked 60 $401.62 8,518 (indirect) −0.7% Oct 16, 2026
Open-market sale 10b5-1 box checked 90 $403.70 8,428 (indirect) −1.1% Oct 16, 2026
Open-market sale 10b5-1 box checked 80 $406.06 8,348 (indirect) −0.9% Oct 16, 2026
Open-market sale 10b5-1 box checked 98 $409.34 8,250 (indirect) −1.2% Oct 16, 2026
Matthew Rabinowitz EXECUTIVE CHAIRMAN · filed Oct 16, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 50,000 $10.41 2,169,394 +2.4% Oct 15, 2026
Open-market sale 10b5-1 box checked 286 $388.32 2,169,108 −0.0% Oct 15, 2026
Open-market sale 10b5-1 box checked 714 $389.84 2,168,394 −0.0% Oct 15, 2026
Open-market sale 10b5-1 box checked 600 $390.21 2,167,794 −0.0% Oct 15, 2026
Open-market sale 10b5-1 box checked 300 $391.58 2,167,494 −0.0% Oct 15, 2026
Open-market sale 10b5-1 box checked 800 $393.47 2,166,694 −0.0% Oct 15, 2026
Open-market sale 10b5-1 box checked 300 $394.40 2,166,394 −0.0% Oct 15, 2026
Open-market sale 10b5-1 box checked 1,900 $396.30 2,164,494 −0.1% Oct 15, 2026
Open-market sale 10b5-1 box checked 1,100 $397.16 2,163,394 −0.1% Oct 15, 2026
Open-market sale 10b5-1 box checked 600 $398.09 2,162,794 −0.0% Oct 15, 2026
Open-market sale 10b5-1 box checked 793 $399.31 2,162,001 −0.0% Oct 15, 2026
Open-market sale 10b5-1 box checked 2,671 $400.31 2,159,330 −0.1% Oct 15, 2026
Open-market sale 10b5-1 box checked 5,974 $401.42 2,153,356 −0.3% Oct 15, 2026
Open-market sale 10b5-1 box checked 6,309 $402.23 2,147,047 −0.3% Oct 15, 2026
Open-market sale 10b5-1 box checked 3,858 $403.27 2,143,189 −0.2% Oct 15, 2026
Open-market sale 10b5-1 box checked 10,321 $404.64 2,132,868 −0.5% Oct 15, 2026
Open-market sale 10b5-1 box checked 6,274 $405.18 2,126,594 −0.3% Oct 15, 2026
Open-market sale 10b5-1 box checked 1,400 $406.63 2,125,194 −0.1% Oct 15, 2026
Open-market sale 10b5-1 box checked 3,800 $407.27 2,121,394 −0.2% Oct 15, 2026
Open-market sale 10b5-1 box checked 2,000 $408.24 2,119,394 −0.1% Oct 15, 2026
Option exercise Stock Option (right to buy) 50,000 — — — Oct 15, 2026
Matthew Rabinowitz EXECUTIVE CHAIRMAN · filed Oct 9, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Gift 6,000 — 2,119,394 −0.3% Oct 7, 2026
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS · filed Oct 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 954 $413.11 108,760 −0.9% Oct 1, 2026
Open-market sale 10b5-1 box checked 1,846 $415.07 106,914 −1.7% Oct 1, 2026
Open-market sale 10b5-1 box checked 200 $411.62 109,714 −0.2% Oct 1, 2026
Steven Leonard Chapman CEO AND PRESIDENT · filed Oct 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 1,273 $413.31 96,926 −1.3% Oct 1, 2026
Jonathan Sheena Director · filed Sep 25, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 400 $385.10 17,632 (indirect) −2.2% Sep 23, 2026
Open-market sale 10b5-1 box checked 2,175 $386.71 15,457 (indirect) −12% Sep 23, 2026
Open-market sale 10b5-1 box checked 2,734 $387.65 12,723 (indirect) −18% Sep 23, 2026
Open-market sale 10b5-1 box checked 1,293 $388.71 11,430 (indirect) −10% Sep 23, 2026
Open-market sale 10b5-1 box checked 2,320 $389.69 9,110 (indirect) −20% Sep 23, 2026
Open-market sale 10b5-1 box checked 110 $390.42 9,000 (indirect) −1.2% Sep 23, 2026
Open-market sale 10b5-1 box checked 390 $385.29 17,642 (indirect) −2.2% Sep 23, 2026
Open-market sale 10b5-1 box checked 2,300 $386.64 15,342 (indirect) −13% Sep 23, 2026
Open-market sale 10b5-1 box checked 2,846 $387.74 12,496 (indirect) −19% Sep 23, 2026
Open-market sale 10b5-1 box checked 1,341 $388.76 11,155 (indirect) −11% Sep 23, 2026
Open-market sale 10b5-1 box checked 1,935 $389.71 9,220 (indirect) −17% Sep 23, 2026
Open-market sale 10b5-1 box checked 220 $390.53 9,000 (indirect) −2.4% Sep 23, 2026
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS · filed Sep 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Gift 945 — 109,914 −0.9% Sep 16, 2026

Listing the 25 most recent of 83 Form 4 filings held for NTRA; the 58 older filings (filed May 5 – Sep 17, 2026) are counted above but not listed here — see NTRA's full Form 4 filing history on SEC EDGAR.

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to NTRA's (Nov 13, 2026).

Frequently asked about NTRA insider activity

How many insiders bought NTRA stock in these Form 4 filings?

No open-market purchases (Form 4 code P) of NTRA shares were reported by Natera, Inc. insiders between May 5, 2026 and Nov 13, 2026. The 83 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.

Who filed the most recent Form 4 for NTRA?

The most recent Form 4 on this page was filed by Jonathan Sheena (Director) on Nov 13, 2026, reporting 14 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market NTRA insider sale shown?

The largest open-market sale among the filings shown was 17,933 NTRA shares at $327.97 (about $5,881,529) by Matthew Rabinowitz (EXECUTIVE CHAIRMAN) on Sep 11, 2026. Value is shares × the price reported on the Form 4; that Form 4 has the Rule 10b5-1 box checked.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for NTRA — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.